FRAGMATIC: a randomised phase III clinical trial investigating the effect of fragmin added to standard therapy in patients with lung cancer - Griffiths, G O; Burns, S; Noble, S I; Macbeth, F R; Cohen, D; Maughan, T S (BMC Cancer, 2009)